Product
Gonadotropin-releasing hormone agonist
2 clinical trials
4 indications
Indication
Tubular Breast CancerIndication
Mucinous Breast CancerIndication
Breast CancerIndication
Inflammatory Breast CancerClinical trial
A Prospective, Randomized, Open-label Comparison of Preoperative Weekly Paclitaxel and Cisplatin With or Without Endocrine Therapy in Patients With Operable Hormone Receptor Positive and Triple Negative Locally Advanced Breast CancerStatus: Active (not recruiting), Estimated PCD: 2019-01-01
Clinical trial
A Randomized Controlled, Open-label, Multicenter Clinical Study of Pyrotinib Maleate Combined With Trastuzumab,Dalpiciclib, and Letrozole Versus Trastuzumab Combined With Pertuzumab, Docetaxel, and Carboplatin as Neoadjuvant Therapy for Stage II-III HR +/HER2 + Breast CancerStatus: Recruiting, Estimated PCD: 2025-12-10